Evaluation of drug therapy and risk factors in diabetic hypertensives: A study of the quality of care provided in diabetic clinics in Bahrain

Journal of Evaluation in Clinical Practice

Volumn 11, Issue 2, 2005, Pages 121-131

  Jassim Al Khaja, Khalid A ^a   Sequeira, Reginald P ^a   Damanhori, Awatif H H ^b  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b Primary Care   (Bahrain)

Author keywords

Diabetic clinic; Diabetic hypertensives; Drug management; Primary care; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; NIFEDIPINE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BAHRAIN; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC HYPERTENSION; DRUG RELEASE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANTIHYPERTENSIVE AGENTS; BAHRAIN; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 15944375888     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2005.00511.x     Document Type: Conference Paper

References (39)

1. American Diabetes Association (ADA) (2003a) Treatment of hypertension in adults with diabetes (position statements). Diabetes Care 26, S80-S82.
2. American Diabetes Association (ADA) (2003b) Aspirin therapy in diabetes (position statements). Diabetes Care 26, S87-S88.
3. American Diabetes Association (ADA) (2003c) Management of dyslipidemia in adults with diabetes (position statements). Diabetes Care 26, S83-S86.
4. Agarwal G., Pierce M. & Ridout D. on behalf of Primary Care Diabetes (the Primary Care Section of British Diabetic Association) (2002) The GP perspective problems experiences in providing diabetes care in UK general practice. Diabetic Medicine 19 (Suppl. 4), 13-20.
5. Al Khaldi Y.M. & Khan M.Y. (2002) Impact of a miniclinic on diabetic care at a primary health care center in Southern Saudi Arabia. Saudi Medical Journal 23, 51-55.
6. Al-Mahroos F. (2000) Diabetes mellitus in the Arabian peninsula. Annals of Saudi Medicine 20, 111-112.
7. Berlowitz D.R., Ash A.S., Hickey B.C., Glickman M., Friedman R. & Kader B. (2003) Hypertension management in patients with diabetes. Diabetes Care 26, 355-359.
8. Antiplatelet Trial Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 308, 81-106. Erratum in: British Medical Journal 308, 1540.
9. Antiplatelet Trial Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 308, 81-106. Erratum in: British Medical Journal 308, 1540.
10. DeFronzo R.A. (1999) Pharmacologic therapy for type 2 diabetes mellitus. Annals of International Medicine 131, 281-303.
11. Epstein M. (2002) Safety of calcium antagonist as antihypertensive agents: an update. In Calcium Antagonist in Clinical Medicine (ed. M. Epstein), pp. 807-832. Hanley and Belfus, Inc, Philadelphia, PA.
12. European Society of Hypertension - European Society of Cardiology (ESH-ESC) (2003) Guidelines for the management of arterial hypertension. Journal of Hypertension 21, 1011-1053.
13. European Arterial Risk Policy Group on behalf of the International Diabetes Federation (European Region) (1997) A strategy for arterial risk assessment and management in type 2 (non-insulin-dependent) diabetes. Diabetic Medicine 14, 611-621.
14. Fonthonne A., Charles M.A. & Julan-Vague I. (1996) The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. Diabetes Care 19, 920-926.
15. Garber A.J., Duncan T.G., Goodman A.M., Mills D.J. & Rohlf J.L. (1997) Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. American Journal of Medicine 103, 491-497.
16. Gregorio F., Ambrosi F., Filipponi P., Manfrini S. & Testa I. (1996) Is metformin safe enough for aging type 2 diabetic patients. Diabetes and Metabolism 22, 43-50.
17. Griffin S. (1998) Diabetes care in general practice: meta-analysis of randomized control trials. British Medical Journal 317, 390-394.
18. Groop L., Luzi L., Melander A., Groop P.H., Ratheiser K., Simonsen D.C. & DeFronzo R.A. (1987) Different effects of glibenclamide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 36, 1320-1328.
19. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K. & Laakso M. (1998) Mortality from coronary heart disease in subjects with and without prior myocardial infarction. New England Journal of Medicine 339, 229-234.
20. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D, Julius S., Menard J, Rahn K.H., Wedel H. & Westerling S. (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomized trial HOT Study Group. Lancet 351, 1755-1762.
21. Herman W.H., Alexander C.M., Cook J.R., Boccuzzi S.J., Musliner T.A., Pedersen T.R., Kjekshus J. & Pyorala K. (1999) Effect of simvastatin treatment on cardio-vascular resource utilization in impaired fasting glucose and diabetes: findings from the Scandinavian Simvastatin Survival Study. Diabetes Care 22, 1771-1778.
22. International Diabetes Federation (2003) Diabetes Atlas, 2nd edn. International Diabetes Federation. Available at http://www.idf.org
23. JNC VII (The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure) (2003) The JNC 7 Report. Journal of American Medical Association 289, 2560-2572.
24. Kaplan N.M. (1989) The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Archives of International Medicine 149, 1514-1520.
25. Khunti K., Ganguli S., Baker R. & Lawly A. (2001) Features of primary care associated with variations in process and outcome of care of people with diabetes. British Journal of General Practice 51, 356-360.
26. Liu L., Wang J.G., Gong L., Liu G. & Staessen J. for the Systolic Hypertension in China (Syst-China) Collaboration Group (1998) Comparison of active treatment and placebo for older patients with isolated systolic hypertension. Journal of Hypertension 16, 1823-1829.
27. Pierce M., Agarwal G. & Ridout D. (2000) A survey of diabetes care in general practice in England and Wales. British Journal of General Practice 50, 542-545.
28. Ramsay L.E., Williams B., Johnston G.D., MacGregor G.A., Poston L., Potter J.F., Poulter N.R. & Russel G. for the British Hypertension Society (1999) Guideline for management of hypertension: report of the third working party of the British Hypertension Society. British Medical Journal 13, 569-592.
29. Ravid M. & Ravid D. (1996) ACE inhibitor in elderly patients with hypertension. Special consideration. Drugs Aging 8, 29-37.
30. Reed R.L., Revel A.O., Carter A., Saadi H.F. & Dunn E.V. (2001) A clinical trial of chronic care diabetic clinics in general practice in the United Arab Emirates: a preliminary analysis. Archives of Physiology and Biochemistry 109, 272-280.
31. Rutten G.E.H.M., Maaijen J., Valkenburg A.C.H., Blankestijn J.G. & de Valk H.W. (2001) The Utrecht Diabetes Project: telemedicine support improves GP care in type 2 diabetes. Diabetic Medicine 18, 459-463.
32. Salman R. (2003) Management of diabetes mellitus in local health centers. Bahrain Medical Bulletin 25, 41-42.
33. Sturmberg J.P. & Overend D. (1999) General practice based diabetes clinics: an integration model. Australian Family Physician 28, 240-245.
34. Tuomilehto J., Rastenyte D., Birkenhager W.H. et al. (1999) Effects of calcium channel blockade in older patients with diabetes and systolic hypertension. Systolic hypertension in Europe trial investigators. New England Journal of Medicine 341, 371-373.
35. UKPDS (UK Prospective Diabetes Study Group) (1998a) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 317, 703-713.
36. UKPDS (UK Prospective Diabetes Study Group) (1998b) Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 352, 837-853.
37. UKPDS (UK Prospective Diabetes Study) (1998c) A 6-year randomized controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy: UKPDS 24. Annals of International Medicine 128, 165-175.
38. World Health Organization (WHO) (1997) World Health Report, 1997. World Health Organization, Geneva.
39. World Health Organization/International Society of Hypertension (WHO/ISH) (1999) Guidelines for the management of hypertension. Guidelines subcommittee. Journal of Hypertension 17, 151-183.